*
*
*
TOP 
Course Schedule Programme
Thursday, November 6th
8.00

Registration

 

8.45

Introduction to the Conference

Pier Franco Conte, Gabriel N. Hortobagyi

SESSION I - PATHOLOGY

Chairmen: Alberto Amadori, Massimo Rugge

9.00

Standardization of breast cancer diagnosis: pathology

Anna Sapino

9.30

Standardization of breast cancer diagnosis: genomics

Giampaolo Bianchini

SESSION II - LOCOREGIONAL THERAPIES

Chairmen: Nicola Balestrieri, Graziano Meneghini

10.00

Evolving loco-regional management

• Post-mastectomy radiotherapy: a new standard? - Philip Poortmans
• Management of the axilla: an update after recent trials - Carlos Garcia Etienne
• Hypofractionated breast irradiation - Philip Poortmans

11.00

Discussion

 

11.20

Coffee break

 

SESSION III - IMAGING

Chairmen: Gabriel N. Hortobagyi, Luigi Pescarini

11.40

Role of MRI in breast cancer diagnosis

Clinical cases will be presented to discuss the following items:
• Is MRI the standard screening procedure in young women? - Enrica Baldan
• Is MRI the gold standard to assess the response to neoadjuvant therapy? - Ilaria Polico
• Is MRI appropriate to plan type of surgery? - Alessandro Coran

 

The audience will be asked to vote. After the vote, two senior speakers will discuss items in favor or contra. The audience will be asked to vote again after the discussion.
- Pro: Pietro Panizza
- Contra: Petra Steyerova

Conclusive remarks of the Chairmen

13.15

Lunch

 

SESSION IV - STAGING AND ADJUVANT

Chairman: Philip Poortmans

14.15

Appropriate work out staging in early breast cancer

Jassem Jacek

14.45

Is there a role for adjuvant bisphosphonates?

Robert Coleman

15.15

Discussion

 

SESSION V - GUIDELINES

Chairman: Philip Poortmans

15.30

Role of guidelines in the era of personalized cancer medicine

• do guidelines impact on patients outcome? - Petra Boelens
• genomics platforms as decision making tools - Miguel Martin

16.30

Adjourn

 

17.30

Ceremony for the presentation of the University of Padua Award for Advances Breast Cancer 2014 and the Monica Boscolo Research Grant

 

18.00

Lecture of the Awardee

 

18.30

Adjourn

 

Friday, November 7th

SESSION VI - EARLY BREAST CANCER

 

9.00

Adjuvant – Clinical Case Discussion I

Chairmen: Pier Franco Conte, Miguel Martin

Presenters of the cases: Zora Baretta, Cristina Falci.
The presenter will introduce a clinical case and will ask questions to the audience. The discussants will comment the vote and will review the state of art.

 

Discussants:
• Fertility preservation - Lucia Del Mastro
• Adjuvant therapy for low risk HER2+ patients - Valentina Guarneri
• Endocrine adjuvant therapy in premenopause - Stephen Johnston
• Extended adjuvant endocrine therapy - Jonas Bergh

10.45

Discussion

 

11.00

Coffee break

 

11.30

Neoadjuvant – Clinical Case Discussion II

Presenters of the cases: Silvia Michieletto, Tania Saibene<br/The presenter will introduce a clinical case and will ask questions to the audience. The discussants will comment the vote and will review the state of art.

 

Discussants:
• Locoregional management - Philip Poortmans
• HR+/HER2 negative - Stephen Johnston
• Triple negative breast cancer - Maria Vittoria Dieci
• Adjuvant therapy in suboptimal responders after neoadjuvant therapy - Pier Franco Conte

13.15

Discussion

 

13.30

Lunch

 

SESSION VII - ADVANCED BREAST CANCER

Chairmen: Valentina Guarneri, Sibylle Loibl

14.30

Clinical case discussion III

The presenter will introduce a clinical case and will ask questions to the audience. The discussants will comment the vote and will review the state of art.

 

• Sequence and duration of anti-HER2 therapy. - Presenter: Cristina Falci, Discussant: Pier Franco Conte
• Therapeutic options for HR+ disease. - Presenter: Carlo Alberto Giorgi, Discussant: Gabriel N. Hortobagyi
• Triple negative advanced breast cancer. - Presenter: Giovanni Faggioni, Discussant: Sabine Linn

16.15

Discussion

 

16.30

Coffee break

 

 

Chairmen: Gabriel N. Hortobagyi, Donato Nitti

16.45

Clinical case discussion IV

The presenter will introduce a clinical case and will ask questions to the audience. The discussants will comment the vote and will review the state of art.

 

• BRCA test as tool for therapy selection. - Presenter: Zora Baretta, Discussant: Miguel Martin
• Surgery of the primary in de novo stage IV disease. - Presenter: Antonella Brunello, Discussant: Miranda Ernst

18.00

Discussion

 

18.10

Adjourn

 

Saturday, November 8th

SESSION VIII - HIGHLIGHTS OF THE YEAR

Chairmen: Jonas Bergh, Stefania Gori

9.00

Advances in biology

Aleix Prat

9.30

HR+/HER2- disease

Stephen Johnston

10.00

HER2+ disease

Fabio Puglisi

10.30

Triple negative disease

Cornelia Liedtke

11.00

Coffee break

 

SESSION IX - COMING SOON

Chairman: Gabriel N. Hortobagyi

11.30

New promising drugs

Jonas Bergh

12.00

Trials likely to impact on clinical practice in the near future: EBC

Sibylle Loibl

12.30

Trials likely to impact on clinical practice in the near future: ABC

Paolo Pronzato

13.00

Adjourn and final evaluation questionnaire

 

TOP 
Directors Speakers
Foto

Pier Franco Conte

Division of Medical Oncology 2

Istituto Oncologico Veneto IRCCS - Department of Surgery, Oncology and Gastroenterology, University of Padua (I)

Scientific Committee

Jonas Bergh

Department of Oncology-Pathology
Karolinska Institute and University Hospital
Stockholm (SW)

Valentina Guarneri

Division of Medical Oncology 2
Istituto Oncologico Veneto IRCCS
Department of Surgery, Oncology and Gastroenterology
University of Padua (I)

Jacek Jassem

Department of Oncology and Radiotherapy
Medical University of Gdansk (PL)

Stephen Johnston

NIHR Biomedical Research Centre for Cancer
Royal Marsden NHS Foundation Trust & Institute of Cancer Research
London (UK)

Speakers & Chairmen

Alberto Amadori

Division of Oncological Molecular Diagnostic and Immunology
Istituto Oncologico Veneto IRCCS
Department of Surgery, Oncology and Gastroenterology
University of Padua (I)

Enrica Baldan

Breast Unit
Division of Medical Oncology 2
Istituto Oncologico Veneto IRCCS
University of Padua (I)

Nicola Balestrieri

Breast Center
AULSS 9 - Cà Foncello Hospital
Treviso (I)

Zora Baretta

Division of Medical Oncology 2
Istituto Oncologico Veneto IRCCS
University of Padua (I)

Jonas Bergh

Department of Oncology-Pathology
Karolinska Institute and University Hospital
Stockholm (SW)

Giampaolo Bianchini

Department of Medical Oncology
IRCCS San Raffaele Hospital
Milan (I)

Petra Boelens

Department of Surgery
Leiden University Medical Center
Leiden (NL)

Fernando Bozza

Division of Breast Surgery
Istituto Oncologico Veneto IRCCS
Padua (I)

Antonella Brunello

Division of Medical Oncology 1
Istituto Oncologico Veneto IRCCS
Padua (I)

Robert E.Coleman

Academic Unit of Clinical Oncology
Weston Park Hospital - University of Sheffield
Sheffield (UK)

Pier Franco Conte

Division of Medical Oncology 2
Istituto Oncologico Veneto IRCCS
Department of Surgery, Oncology and Gastroenterology
University of Padua (I)

Alessandro Coran

Breast Imaging Unit
Istituto Oncologico Veneto IRCCS
Padua (I)

Lucia Del Mastro

Medical Oncology A- Innovative therapies development
National Institute for Cancer Research
Genoa (I)

Maria Vittoria Dieci

Division of Medical Oncology 2
Istituto Oncologico Veneto IRCCS
Department of Surgery, Oncology and Gastroenterology
University of Padua (I)

Miranda Ernst

Division of Oncology Surgery
Alexander Monro Clinic
Bernhoven (NL)

Carlos Garcia Etienne

Division of Breast Surgery
Humanitas Research Hospital
Rozzano (I)

Giovanni Faggioni

Division of Medical Oncology 2
Istituto Oncologico Veneto IRCCS
Padua (I)

Cristina Falci

Division of Medical Oncology 2
Istituto Oncologico Veneto IRCCS
University of Padua (I)

Carlo Alberto Giorgi

Division of Medical Oncology 2
Istituto Oncologico Veneto IRCCS
Padua (I)

Stefania Gori

Department of Medical Oncology
Sacro Cuore - Don Calabria Hospital
Negrar, VR (I)

Valentina Guarneri

Division of Medical Oncology 2
Istituto Oncologico Veneto IRCCS
Department of Surgery, Oncology and Gastroenterology
University of Padua (I)

Foto

Gabriel N. Hortobagyi

Department of Breast Medical Oncology

University of Texas - MD Anderson Cancer Center, Houston (USA)

 

Sibylle Loibl

German Breast Group
Department of Medicine and Reasearch
University of Frankfurt (D)

Miguel Martin

Medical Oncology Service
Hospital Universitario Gregorio Maranon
Madrid (S)

Donato Nitti

Department of Surgery, Oncology and Gastroenterology
University of Padua (I)

Philip Poortmans

President-elect of ESTRO
Department of Radiation Oncology
Dr. Verbeeten Instituut
Tilburg (NL)

 

Gabriel N. Hortobagyi

Department of Breast Medical Oncology
University of Texas - MD Anderson Cancer Center
Houston (USA)

Jacek Jassem

Department of Oncology and Radiotherapy
Medical University of Gdansk (PL)

Stephen Johnston

NIHR Biomedical Research Centre for Cancer
Royal Marsden NHS Foundation Trust & Institute of Cancer Research
London (UK)

Cornelia Liedtke

Campus Lübeck Department of Gynecology and Obstetrics
University Hospital of Schleswig-Holstein
Lubeck (D)

Sabine Linn

Division of Molecular Pathology
Netherlands Cancer Institute
Amsterdam (NL)

Sibylle Loibl

German Breast Group
Department of Medicine and Reasearch
University of Frankfurt (D)

Graziano Meneghini

Breast Center
ULSS 5 Ovest Vicentino
Montecchio Maggiore (VI)

Miguel Martin

Medical Oncology Service
Hospital Universitario Gregorio Maranon
Madrid (S)

Silvia Michieletto

Division of Breast Surgery
Istituto Oncologico Veneto IRCCS
Padua (I)

Donato Nitti

Department of Surgery, Oncology and Gastroenterology
University of Padua (I)

Pietro Panizza

Department of Diagnostic Radiology
National Cancer Institute
Milan (I)

Luigi Pescarini

Department of Radiology
Diagnostic Breast Unit
Istituto Oncologico Veneto IRCCS
University of Padua (I)

Ilaria Polico

Breast Imaging Unit
Istituto Oncologico Veneto IRCCS
Padua (I)

Philip Poortmans

President-elect of ESTRO
Department of Radiation Oncology
Radbound University Medical Centre
Nijmegen (NL)

Aleix Prat

Institute of Oncology (VHIO)
Vall d’Hebron
Barcellona (E)

Paolo Pronzato

Department of Medical Oncology
National Cancer Institute
Genoa (I)

Fabio Puglisi

Department of Oncology
University Hospital of Udine (I)

Massimo Rugge

General Pathology & Cytopathology Unit
Department of Medicine-DIMED
University of Padua (I)

Tania Saibene

Division of Breast Surgery
Istituto Oncologico Veneto IRCCS
Padua (I)

Anna Sapino

Department of Biomedical Science and Human Oncology
University of Torino (I)

Petra Steyerova

Center for Breast Disease
V. Polak Clinic of Radiology
General University Hospital
Prague (CS)

TOP 

AIBCC - Meet The Professor

Breast cancer mortality is declining in most countries; a detailed knowledge of the mechanisms of cancer progression, phenotypic and genotypic characterization of the disease, screening programs, advanced imaging, local therapies and molecularly targeted drugs have all been fundamental to achieve this success. Nowadays, breast cancer represents the front runner in the path to comparative effectiveness, where new therapeutic interventions are implemented on the basis of "average" benefit, to personalized cancer medicine, where the right treatment is provided to the right patient at the right moment. An updated, multifaceted approach to our patients is now becoming more and more demanding and with these goals in mind, the Programme of this international Conference includes lectures on molecular characterization, updated management of early and advanced disease, strategies to overcome resistance to available therapies, innovative therapies, and multimodal treatments for advanced disease.

Clinical case discussions and debates are planned to allow a continuous and fruitful exchange of experiences and opinions between speakers and participants.

This 10th Breast Cancer Conference includes a highly qualified international faculty, but will maintain its characteristics of a friendly forum where international opinion leaders and attendees will exchange experiences and share the most exiting advances.

In order to reward scientific excellence and to foster international cooperation, the International Scientific Committee of the 10th AIBCC will award the 4th International Prize for Breast Cancer Research to a scientist who has published a breakthrough paper in the previous year and the Monica Boscolo Research Grant to an Italian scientist for a research project to be conducted in cooperation with a foreign institution.

We welcome medical oncologists, pathologists, breast surgeons, radiation oncologists and basic scientists to listen to breast cancer leaders and to exchange experiences in a friendly atmosphere.

AWARDS

  • MONICA BOSCOLO RESEARCH GRANT
    The Scientific Committee will select the winner of the Monica Boscolo Research Grant. This Research Award is restricted to young Italian researchers (< 40 years) who will carry out a research project in cooperation with a foreign institution.
    Download application form (PDF)

  • UNIVERSITY OF PADUA AWARD FOR ADVANCES IN BREAST CANCER 2014
    The Scientific Committee will nominate a young researcher (< 40 years from any country) who has published, as the principal author, in an international peer-reviewed journal, a manuscript reporting important clinical or biological advances in breast cancer. The winner will be invited to present his/her study during the annual Conference.
    Download application form (PDF)



ADDRESSED TO

Oncologists, pathologists, radiologists, radiation oncologists, surgeons, gynaecologists, biologists and nurses

OFFICIAL LANGUAGE

The official language of the Meeting is English. No simultaneous translation will be provided.

CME

Based on the in force Italian regulations, Accademia Nazionale di Medicina (provider n. 31) will assign to the activity CME (31-99451): 8 CME points.

The Meeting is addressed to physicians specialized in oncology, radiodiagnostics, radiotherapy, clinical pathology, general surgery, gynaecology and obstetrics, biologists and nurses. It will not be possible to give credits to physicians specialized in different fields.

The credit certification is subject to:

  • attendance at the entire Meeting
  • the completion of the Meeting evaluation form
  • the completion of the final questionnaire (at least 75% of correct answers)

Free admission is available for 5 persons “Under 35”. Registration forms will be accepted on a first-come, first-serve basis until spaces are filled. The Organization Secretary will confirm the registration by email.

With the patronage of

Institutions

Regione Veneto Comune di Padova Università di Padova Università di Padova - DISCOG Azienda Ospedaliera di Padova Istituto Oncologico VenetoRete Oncologica Veneta

Scientific Societies

AIOM AIRO CIPOMO Collegio degli Oncologi Medici Universitari ESMO ESTRO FEAM Senology

With the unconditional contribution of

Gold sponsor

Celgene Roche

Silver sponsor

Astrazeneca GSK Lilly Oncology Novartis

Bronze sponsor

Bristol-Myers Squibb Teva

Contributors

EISAI | GENOMIC HEALTH | MYRIAD GENETICS | PHARMA MAR | PIERRE FABRE PHARMA | SANOFI AVENTIS

TOP 
How to Attend Location

Location:

Centro Congressi Padova A. Luciani
Via Forcellini 170/A
35128 Padova, Italy

How to reach the meeting venue